IRC
AGN

Investors Research Corp’s Allergan plc AGN Stock Holding History

Investors Research Corp’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-200
Closed -$35K – 1150
2020
Q1 		$35K Hold
200
– – 0.02% 505
2019
Q4 		$38K Hold
200
– – 0.02% 569
2019
Q3 		$34K Hold
200
– – 0.02% 574
2019
Q2 		$33K Hold
200
– – 0.02% 582
2019
Q1 		$29K Buy
+200
New +$29K 0.02% 593

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Investors Research Corp's AGN Position: Q2 2020 in Review

Investors Research Corp sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 200 shares — an estimated $35K sold.

Investors Research Corp first reported a position in AGN in Q1 2019 and held it in 5 quarters. The position peaked at $38K in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Investors Research Corp reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Investors Research Corp sold 200 Allergan plc shares in Q2 2020, an estimated $35K.
  • Investors Research Corp first reported a position in Allergan plc in Q1 2019 and held it in 5 quarters.
  • Investors Research Corp's Allergan plc position peaked at $38K in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Investors Research Corp's 13F filing for Q2 2020, filed 21 Jul 2020.